The Mirai AI model significantly improves detection of interval breast cancers in negative screening mammograms.
Key Details
- 1Mirai risk model analyzed 134,217 screening mammograms, including 524 interval cancers.
- 2Top 20% risk group by Mirai captured 42.4% of interval cancers, corresponding to 1.7 additional detections per 1,000 exams.
- 3AUC values for interval cancer prediction ranged from 0.67 to 0.72 across time, age, and breast density subgroups.
- 4No significant performance variation across different age groups or breast densities was observed.
- 5Mirai has been validated on nearly 2 million mammograms across 21 countries.
- 6Editorial comments highlight progress but note limitations since interval cancer detection did not surpass 50%.
Why It Matters
Interval cancers are a challenge in breast screening, often missed during routine exams and harder to detect. AI-driven risk models like Mirai offer a promising path to personalized screening strategies, potentially catching cancers earlier and improving patient outcomes.
Source
AuntMinnie
Related News
•Radiology Business
NYC Health + Hospitals CEO Considers AI to Replace Radiologists
NYC Health + Hospitals CEO suggests AI could partially replace radiologists, pending regulatory approval.
•Radiology Business
UCLA Appoints Inaugural Associate Dean for Health AI Strategy
UCLA has appointed Katherine P. Andriole as its first associate dean for Health AI Strategy and Innovation, with an initial focus on radiology.
•AuntMinnie
AI Models Reveal Racial Disparities in Breast Cancer Patterns
Machine learning models reveal significant racial disparities and key predictors in breast cancer incidence across diverse groups.